Ann: Update on Product Offtake-PLS.AX, page-328

First 328 Last

Share
Profile

Follow
Gordo7

637 Posts.

281

26/07/16

12:47

Post #: 18367530
Share

Originally posted by Hogram ↑

I'm not stressed at all with the SP drop. People are simply panicking because they don't understand what's happening. So here it is in lamen's terms.

Pilbara bought the land from GAM where all this lovely lithium is buried. Within this sale an agreement was made that when PLS started selling lithium, GAM would get the right to match any price that any third party offered first with a 45 day limit (This is a good thing. It means PLS either sells its lithium to a third party or it definitely sells its lithium to GAM - it's a win/win).

Fast track a little bit, and a spanner has been thrown in the works. Along comes MIN and they acquire GAM. Now MIN want the Right of First Refusal (ROFR) that GAM had in place. (Again, great news. Now GAM wants to buy too, so PLS either sell to a third party, sell to GAM, or sell to MIN- win, win, or win).

So does any of this matter? No. All it means is that PLS will either be bound to the original agreement with GAM and sell its lithium, be bound to the same agreement with MIN and sell its lithium, or be bound to no one and sell its lithium. Either way, it's business as usual and PLS now have two buyers fighting hard over over first bite of its lit.

Add to that, the market is now in massive turmoil over this (look at today's volume for gods sake), so PLS is being heard of across oceans and seas. This is actually GOOD PR - the PR we've been needing.

Hold your damn shares or buy more if you can afford to. This is annoying, but it's good news. And nothing has changed for PLS' future. We are not going broke. We are not being taken over. We are okay.

Disclaimer: I know I've missed a lot of details in the info above bit I've tried to keep it very simple for the masses.

DYOR as always. I'm just a guy.

Expand

Thanks Hogram, nice to have this put into simple terms for us simple folk

P.S. Also hold EDE - you know what's good around these parts

PLS Price at posting: 50.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 348 more messages in this thread...

First 328 Last

Add PLS (ASX) to my watchlist

(20min delay)
Last $3.01		Change 0.050(1.69%)		Mkt cap ! $9.059B

Open	High	Low	Value	Volume
$3.03	$3.04	$2.96	$47.61M	15.86M

Buyers (Bids)

No.	Vol.	Price($)
14	168080	$3.00

Sellers (Offers)

Price($)	Vol.	No.
$3.01	137639	2

View Market Depth

No.	Vol.	Price($)
11	75689	3.000
7	205449	2.990
12	407672	2.980
24	238752	2.970
25	78701	2.960

Price($)	Vol.	No.
3.010	67232	1
3.020	176193	15
3.030	267726	16
3.040	299668	20
3.050	191927	24

Last trade - 16.10pm 09/07/2024 (20 minute delay)

PLS (ASX) Chart

Ann: Update on Product Offtake-PLS.AX, page-328

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Update on Product Offtake-PLS.AX, page-328

Top Stories

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News